CRISPR-Cas in Drug Discovery and Therapy
- Science for Admin
Christof Fellmann, PhD
Christof Fellmann’s research has helped to establish and optimize the use of RNA-guided immune systems such as CRISPR-Cas for applications in biomedicine. At Gladstone, his group is developing and using CRISPR gene editing tools to better understand the genetics of certain cancers and other diseases, and to establish novel therapeutic strategies for patients.